As of 2024-12-11, the Intrinsic Value of Scandion Oncology A/S (SCOL.ST) is
-1.20 SEK. This SCOL.ST valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.08 SEK, the upside of Scandion Oncology A/S is
-1,693.84%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-1.20 SEK
Intrinsic Value
SCOL.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
Fair Value |
-1.20 - -1.20 |
-1.20 |
-1,693.84% |
P/E |
0.07 - 0.07 |
0.07 |
-4.4% |
DDM - Stable |
(5.52) - 56.67 |
25.58 |
34002.1% |
DDM - Multi |
(11.93) - 94.21 |
(27.13) |
-36267.0% |
SCOL.ST Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
17.39 |
Beta |
0.12 |
Outstanding shares (mil) |
231.93 |
Enterprise Value (mil) |
-23.98 |
Market risk premium |
5.10% |
Cost of Equity |
5.33% |
Cost of Debt |
5.00% |
WACC |
5.28% |